Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies ; volume:10 ; number:1 ; day:14 ; month:7 ; year:2010 ; pages:1-7 ; date:12.2010
BMC cancer ; 10, Heft 1 (14.7.2010), 1-7, 12.2010
- Urheber
-
Javle, Milind M.
- Beteiligte Personen und Organisationen
-
Shroff, Rachna T.
Xiong, Henry
Varadhachary, Gauri A.
Fogelman, David
Reddy, Shrikanth A.
Davis, Darren
Zhang, Yujian
Wolff, Robert A.
Abbruzzese, James L.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-368
- URN
-
urn:nbn:de:1111-2016030359877
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Javle, Milind M.
- Shroff, Rachna T.
- Xiong, Henry
- Varadhachary, Gauri A.
- Fogelman, David
- Reddy, Shrikanth A.
- Davis, Darren
- Zhang, Yujian
- Wolff, Robert A.
- Abbruzzese, James L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Mammalian target of rapamycin signaling in diabetic cardiovascular disease
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Mammalian target of rapamycin signaling in diabetic cardiovascular disease